Chronic kidney disease is associated with the incidence of atrial fibrillation: the Atherosclerosis Risk in Communities (ARIC) study
- PMID: 21646496
- PMCID: PMC3139978
- DOI: 10.1161/CIRCULATIONAHA.111.020982
Chronic kidney disease is associated with the incidence of atrial fibrillation: the Atherosclerosis Risk in Communities (ARIC) study
Abstract
Background: Chronic kidney disease is associated with the incidence of cardiovascular disease. Chronic kidney disease may also increase the risk of atrial fibrillation (AF), but existing studies have reported inconsistent results.
Methods and results: We estimated cystatin C-based glomerular filtration rate (eGFR(cys)) and measured urinary albumin-to-creatinine ratio (ACR) in 10 328 men and women free of AF from the Atherosclerosis Risk in Communities (ARIC) Study in 1996 to 1998. Incidence of AF was ascertained through the end of 2007. During a median follow-up of 10.1 years, we identified 788 incident AF cases. Compared with individuals with eGFR(cys) ≥90 mL · min(-1) · 1.73 m(-2), multivariable hazard ratios and 95% confidence intervals (CIs) of AF were 1.3 (95% CI, 1.1 to 1.6), 1.6 (95% CI, 1.3 to 2.1), and 3.2 (95% CI, 2.0 to 5.0; P for trend <0.0001) in those with eGFR(cys) of 60 to 89, 30 to 59, and 15 to 29 mL · min(-1) · 1.73 m(-2), respectively. Similarly, the presence of macroalbuminuria (ACR ≥300 mg/g; hazard ratio, 3.2; 95% CI, 2.3 to 4.5) and microalbuminuria (ACR, 30 to 299 mg/g; hazard ratio, 2.0; 95% CI, 1.6 to 2.4) was associated with higher AF risk compared with those with ACR <30 mg/g. Risk of AF was particularly elevated in those with both low eGFR(cys) and macroalbuminuria (hazard ratio, 13.1; 95% CI, 6.0 to 28.6, comparing individuals with ACR ≥300 mg/g and eGFR(cys) of 15 to 29 mL · min(-1) · 1.73 m(-2) and those with ACR <30 mg/g and eGFR(cys) ≥90 mL · min(-1) · 1.73 m(-2)).
Conclusion: In this large population-based study, reduced kidney function and presence of albuminuria were strongly associated with the incidence of AF independently of other risk factors.
Figures
Comment in
-
Cardiovascular disease: CKD increases the risk of atrial fibrillation.Nat Rev Nephrol. 2011 Jul 5;7(8):426. doi: 10.1038/nrneph.2011.80. Nat Rev Nephrol. 2011. PMID: 21727924 No abstract available.
Similar articles
-
Relation of kidney function and albuminuria with atrial fibrillation (from the Heart and Soul Study).Am J Cardiol. 2009 Dec 1;104(11):1551-5. doi: 10.1016/j.amjcard.2009.07.026. Am J Cardiol. 2009. PMID: 19932791 Free PMC article.
-
Association of Proteinuria and Incident Atrial Fibrillation in Patients With Intact and Reduced Kidney Function.J Am Heart Assoc. 2017 Jul 6;6(7):e005685. doi: 10.1161/JAHA.117.005685. J Am Heart Assoc. 2017. PMID: 28684642 Free PMC article.
-
Reduced kidney function is a risk factor for atrial fibrillation.Nephrology (Carlton). 2016 Aug;21(8):717-20. doi: 10.1111/nep.12727. Nephrology (Carlton). 2016. PMID: 26780558
-
Chronic Kidney Disease and Risk for Gastrointestinal Bleeding in the Community: The Atherosclerosis Risk in Communities (ARIC) Study.Clin J Am Soc Nephrol. 2016 Oct 7;11(10):1735-1743. doi: 10.2215/CJN.02170216. Epub 2016 Aug 11. Clin J Am Soc Nephrol. 2016. PMID: 27515592 Free PMC article.
-
eGFR and Albuminuria in Relation to Risk of Incident Atrial Fibrillation: A Meta-Analysis of the Jackson Heart Study, the Multi-Ethnic Study of Atherosclerosis, and the Cardiovascular Health Study.Clin J Am Soc Nephrol. 2017 Sep 7;12(9):1386-1398. doi: 10.2215/CJN.01860217. Epub 2017 Aug 10. Clin J Am Soc Nephrol. 2017. PMID: 28798221 Free PMC article.
Cited by
-
Kidney function, uric acid, and risk of atrial fibrillation: experience from the AMORIS cohort.BMC Cardiovasc Disord. 2024 Oct 22;24(1):581. doi: 10.1186/s12872-024-04236-9. BMC Cardiovasc Disord. 2024. PMID: 39438792 Free PMC article.
-
High premature atrial complex burden and risk of renal function decline.Clin Kidney J. 2024 Jul 4;17(8):sfae208. doi: 10.1093/ckj/sfae208. eCollection 2024 Aug. Clin Kidney J. 2024. PMID: 39421240 Free PMC article.
-
Evaluating the Prognostic Significance of Cystatin C Level Variations Pre- and Post-Radiofrequency Catheter Ablation in the Recurrence of Persistent Atrial Fibrillation.Ann Noninvasive Electrocardiol. 2024 Nov;29(6):e70024. doi: 10.1111/anec.70024. Ann Noninvasive Electrocardiol. 2024. PMID: 39412033 Free PMC article.
-
Effect of impaired kidney function on outcomes and treatment effects of oral anticoagulant regimes in patients with atrial fibrillation in a real-world registry.PLoS One. 2024 Sep 23;19(9):e0310838. doi: 10.1371/journal.pone.0310838. eCollection 2024. PLoS One. 2024. PMID: 39312541 Free PMC article.
-
Association of Estimated Glomerular Filtration Rate Trajectories with Atrial Fibrillation Risk in Populations with Normal or Mildly Impaired Renal Function.Kidney Dis (Basel). 2024 May 20;10(4):274-283. doi: 10.1159/000539289. eCollection 2024 Aug. Kidney Dis (Basel). 2024. PMID: 39131881 Free PMC article.
References
-
- Astor BC, Coresh J, Heiss G, Pettitt D, Sarnak MJ. Kidney function and anemia as risk factors for coronary heart disease and mortality: the Atherosclerosis Risk in Communities (ARIC) Study. Am Heart J. 2006;151:492–500. - PubMed
-
- Kottgen A, Russell SD, Loehr LR, Crainiceanu CM, Rosamond WD, Chang PP, Chambless LE, Coresh J. Reduced kidney function as a risk factor for incident heart failure: the Atherosclerosis Risk in Communities (ARIC) Study. J Am Soc Nephrol. 2007;18:1307–1315. - PubMed
-
- Wattanakit K, Folsom AR, Selvin E, Coresh J, Hirsch AT, Weatherley BD. Kidney function and risk of peripheral arterial disease: results from the Atherosclerosis Risk in Communities (ARIC) Study. J Am Soc Nephrol. 2007;18:629–636. - PubMed
-
- Sarnak MJ, Levey AS, Schoolwerth AC, Coresh J, Culleton B, Hamm LL, McCullough PA, Kasiske BL, Kelepouris E, Klag MJ, Parfrey P, Pfeffer M, Raij L, Spinosa DJ, Wilson PW. Kidney disease as a risk factor for development of cardiovascular disease: a statement from the American Heart Association Councils on Kidney in Cardiovascular Disease, High Blood Pressure Research, Clinical Cardiology, and Epidemiology and Prevention. Circulation. 2003;108:2154–2169. - PubMed
Publication types
MeSH terms
Grants and funding
- N01HC55018/HL/NHLBI NIH HHS/United States
- N01-HC55021/HC/NHLBI NIH HHS/United States
- N01-HC55015/HC/NHLBI NIH HHS/United States
- N01 HC055018/HC/NHLBI NIH HHS/United States
- RC1 HL099452/HL/NHLBI NIH HHS/United States
- N01HC55015/HL/NHLBI NIH HHS/United States
- N01-HC55019/HC/NHLBI NIH HHS/United States
- N01 HC055019/HC/NHLBI NIH HHS/United States
- R01 DK076770-01/DK/NIDDK NIH HHS/United States
- RC1-HL099452/HL/NHLBI NIH HHS/United States
- N01HC55016/HL/NHLBI NIH HHS/United States
- N01 HC055021/HC/NHLBI NIH HHS/United States
- RC1 HL099452-01/HL/NHLBI NIH HHS/United States
- N01 HC055020/HC/NHLBI NIH HHS/United States
- N01 HC055016/HC/NHLBI NIH HHS/United States
- N01HC55020/HL/NHLBI NIH HHS/United States
- N01 HC055022/HC/NHLBI NIH HHS/United States
- N01HC55022/HL/NHLBI NIH HHS/United States
- N01-HC55022/HC/NHLBI NIH HHS/United States
- N01-HC55018/HC/NHLBI NIH HHS/United States
- R01 DK076770/DK/NIDDK NIH HHS/United States
- N01 HC055015/HC/NHLBI NIH HHS/United States
- RC1 HL099452-02/HL/NHLBI NIH HHS/United States
- N01HC55019/HL/NHLBI NIH HHS/United States
- N01-HC55016/HC/NHLBI NIH HHS/United States
- N01HC55021/HL/NHLBI NIH HHS/United States
- R01-DK076770/DK/NIDDK NIH HHS/United States
- N01-HC55020/HC/NHLBI NIH HHS/United States
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Research Materials
Miscellaneous
